130 related articles for article (PubMed ID: 18753229)
1. Relevance of viral context and diversity of antigen-processing routes for respiratory syncytial virus cytotoxic T-lymphocyte epitopes.
Johnstone C; Guil S; Rico MA; García-Barreno B; López D; Melero JA; Del Val M
J Gen Virol; 2008 Sep; 89(Pt 9):2194-2203. PubMed ID: 18753229
[TBL] [Abstract][Full Text] [Related]
2. Exogenous, TAP-independent lysosomal presentation of a respiratory syncytial virus CTL epitope.
Johnstone C; Ramos M; García-Barreno B; López D; Melero JA; Del Val M
Immunol Cell Biol; 2012 Nov; 90(10):978-82. PubMed ID: 22929180
[TBL] [Abstract][Full Text] [Related]
3. Processing of a multiple membrane spanning Epstein-Barr virus protein for CD8(+) T cell recognition reveals a proteasome-dependent, transporter associated with antigen processing-independent pathway.
Lautscham G; Mayrhofer S; Taylor G; Haigh T; Leese A; Rickinson A; Blake N
J Exp Med; 2001 Oct; 194(8):1053-68. PubMed ID: 11602636
[TBL] [Abstract][Full Text] [Related]
4. Shifting immunodominance pattern of two cytotoxic T-lymphocyte epitopes in the F glycoprotein of the Long strain of respiratory syncytial virus.
Johnstone C; de León P; Medina F; Melero JA; García-Barreno B; Val MD
J Gen Virol; 2004 Nov; 85(Pt 11):3229-3238. PubMed ID: 15483236
[TBL] [Abstract][Full Text] [Related]
5. Characterization of TAP-independent and brefeldin A-resistant presentation of Sendai virus antigen to CD8+ cytotoxic T lymphocytes.
Zhou X; Liu T; Franksson L; Lederer E; Ljunggren HG; Jondal M
Scand J Immunol; 1995 Jul; 42(1):66-75. PubMed ID: 7631147
[TBL] [Abstract][Full Text] [Related]
6. Furin-processed antigens targeted to the secretory route elicit functional TAP1-/-CD8+ T lymphocytes in vivo.
Medina F; Ramos M; Iborra S; de León P; Rodríguez-Castro M; Del Val M
J Immunol; 2009 Oct; 183(7):4639-47. PubMed ID: 19752221
[TBL] [Abstract][Full Text] [Related]
7. Evidence of selective processing of immunodominant epitopes in virally infected cells.
Zhang QJ; Chen SS; Saari CA; Massuci MG; Tufaro F; Jefferies WA
J Immunol; 2000 May; 164(9):4513-21. PubMed ID: 10779752
[TBL] [Abstract][Full Text] [Related]
8. A measles virus glycoprotein-derived human CTL epitope is abundantly presented via the proteasomal-dependent MHC class I processing pathway.
Herberts CA; Stittelaar KJ; van der Heeft E; van Gaans-van den Brink J; Poelen MCM; Roholl PJM; van Alphen LJW; Melief CJM; de Jong APJM; van Els CACM
J Gen Virol; 2001 Sep; 82(Pt 9):2131-2142. PubMed ID: 11514722
[TBL] [Abstract][Full Text] [Related]
9. Multiple antigen-specific processing pathways for activating naive CD8+ T cells in vivo.
Norbury CC; Princiotta MF; Bacik I; Brutkiewicz RR; Wood P; Elliott T; Bennink JR; Yewdell JW
J Immunol; 2001 Apr; 166(7):4355-62. PubMed ID: 11254689
[TBL] [Abstract][Full Text] [Related]
10. Sequential cleavage by metallopeptidases and proteasomes is involved in processing HIV-1 ENV epitope for endogenous MHC class I antigen presentation.
López D; Gil-Torregrosa BC; Bergmann C; Del Val M
J Immunol; 2000 May; 164(10):5070-7. PubMed ID: 10799863
[TBL] [Abstract][Full Text] [Related]
11. Peptide transporter (TAP-1 and TAP-2)-independent endogenous processing of Epstein-Barr virus (EBV) latent membrane protein 2A: implications for cytotoxic T-lymphocyte control of EBV-associated malignancies.
Khanna R; Burrows SR; Moss DJ; Silins SL
J Virol; 1996 Aug; 70(8):5357-62. PubMed ID: 8764046
[TBL] [Abstract][Full Text] [Related]
12. Antigen presentation in syrian hamster cells: substrate selectivity of TAP controlled by polymorphic residues in TAP1 and differential requirements for loading of H2 class I molecules.
Lobigs M; Müllbacher A; Blanden RV; Hämmerling GJ; Momburg F
Immunogenetics; 1999 Oct; 49(11-12):931-41. PubMed ID: 10501835
[TBL] [Abstract][Full Text] [Related]
13. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
[TBL] [Abstract][Full Text] [Related]
14. Preventing vaccinia virus class-I epitopes presentation by HSV-ICP47 enhances the immunogenicity of a TAP-independent cancer vaccine epitope.
Raafat N; Sadowski-Cron C; Mengus C; Heberer M; Spagnoli GC; Zajac P
Int J Cancer; 2012 Sep; 131(5):E659-69. PubMed ID: 22116674
[TBL] [Abstract][Full Text] [Related]
15. In vitro processing and presentation of a lipidated cytotoxic T-cell epitope derived from measles virus fusion protein.
Stittelaar KJ; Hoogerhout P; Ovaa W; van Binnendijk RR; Poelen MC; Roholl P; van Els CA; Osterhaus AD; Wiertz EJ
Vaccine; 2001 Oct; 20(1-2):249-61. PubMed ID: 11567771
[TBL] [Abstract][Full Text] [Related]
16. Recombinant influenza virus carrying the respiratory syncytial virus (RSV) F85-93 CTL epitope reduces RSV replication in mice.
De Baets S; Schepens B; Sedeyn K; Schotsaert M; Roose K; Bogaert P; Fiers W; Saelens X
J Virol; 2013 Mar; 87(6):3314-23. PubMed ID: 23302879
[TBL] [Abstract][Full Text] [Related]
17. Transporter (TAP)-independent processing of a multiple membrane-spanning protein, the Epstein-Barr virus latent membrane protein 2.
Lee SP; Thomas WA; Blake NW; Rickinson AB
Eur J Immunol; 1996 Aug; 26(8):1875-83. PubMed ID: 8765034
[TBL] [Abstract][Full Text] [Related]
18. IFN-beta mediates coordinate expression of antigen-processing genes in RSV-infected pulmonary epithelial cells.
Jamaluddin M; Wang S; Garofalo RP; Elliott T; Casola A; Baron S; Brasier AR
Am J Physiol Lung Cell Mol Physiol; 2001 Feb; 280(2):L248-57. PubMed ID: 11159003
[TBL] [Abstract][Full Text] [Related]
19. Identification of sequences in the human peptide transporter subunit TAP1 required for transporter associated with antigen processing (TAP) function.
Ritz U; Momburg F; Pircher HP; Strand D; Huber C; Seliger B
Int Immunol; 2001 Jan; 13(1):31-41. PubMed ID: 11133832
[TBL] [Abstract][Full Text] [Related]
20. Recognition of respiratory syncytial virus fusion protein by mouse cytotoxic T cell clones and a human cytotoxic T cell line.
Cannon MJ; Bangham CR
J Gen Virol; 1989 Jan; 70 ( Pt 1)():79-87. PubMed ID: 2471784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
